Smoking and the Larynx: From Vocal Damage to Laryngeal Cancer

Cigarette smoke passes through the larynx and vocal cords on its way to the lungs. Over 7,000 chemicals in smoke; at least 70 are carcinogens (DNA-damaging, tumour-inducing). They contact the mucosa directly with every puff, causing micro-burns and microscopic DNA damage. Over years this cumulative harm develops into clear pathologies.

First changes are chronic inflammation. The mucosa is persistently oedematous, hypervascular, with thickened epithelium — chronic laryngitis. Voice quality drops ("smoker's voice"), persistent throat dryness and clearing, mild cough. Smokers accept this as "normal" — but it's pathological.

The effect is not just chemical but also thermal. Smoke is ~60°C; every puff exposes the mucosa to a small heat shock. This causes heat-induced protein denaturation and increased mucosal sensitivity. We expand on the clinical framework in our laryngology and voice surgery unit.

Reinke's oedema is soft-tissue swelling of the vocal cords developing in long-term smokers. Clinically: gel-like fluid accumulates just under the mucosa in Reinke's space (the thin tissue layer between cartilage and mucosa). Result: the vocal cords are thicker than normal, vibration is heavier, voice deepens and grows raspy.

Effect is especially dramatic in women — normal female voice 200-260 Hz; with Reinke's it drops to 120-160 Hz (lower than typical male voice). The patient complains "people think I'm a man on the phone". Classic finding: a "smoked-wine" deep voice.

Treatment: first and most effective step — quit smoking. No treatment is durable while smoking continues. After cessation, oedema partly regresses in 6-12 months. If still pronounced, surgery (microlaryngoscopy drains the subepithelial fluid, prevents reattachment). Voice therapy is needed post-op.

Reinke's oedema is not premalignant, but the cords have endured years of smoking; concurrent leukoplakia or cancer risk exists. So a Reinke's oedema diagnosis mandates a comprehensive laryngology evaluation.

A white, well-demarcated, thick-looking lesion on the vocal cord — leukoplakia, "the white plaque". Endoscopy shows a typical appearance; it does not scrape off, distinguishing it from infections like candidiasis.

Leukoplakia is a description, not a diagnosis — what it represents microscopically is determined by biopsy. 50% are mild dysplasia (simple cell change), 25% moderate, 15% severe (close to cancer), 10% already in-situ or invasive cancer. So leukoplakia is a "warning sign" — observation alone is not enough.

On diagnosis: biopsy is MANDATORY. Excisional biopsy (complete removal of the lesion) is ideal both diagnostically and therapeutically. Mild dysplasia — excision suffices; severe dysplasia — excision + close follow-up; in-situ cancer — excision + radiotherapy option.

Smoking cessation is critical. If smoking continues, leukoplakia progresses, additional lesions develop. Some lesions may regress after cessation; aggressive dysplasia does not.

Laryngeal cancer risk is 15× higher in smokers vs. never-smokers. Alcohol use compounds the risk — combined smoking + alcohol multiplies risk 35-40×. Türkiye's 5th most common cancer in men; mortality is low in early-stage cases but high in delayed cases.

Early signs (Stage I-II): hoarseness >2 weeks (the most important sign), throat fullness, mild sore throat, one-sided ear pain (referred pain). These signs are commonly dismissed — the main cause of delayed diagnosis.

Late signs (Stage III-IV): total voice loss or "barking" pathological voice, dysphagia, dyspnoea (stridor — airway narrowing), neck lymph node (metastasis), weight loss, blood-tinged sputum.

Diagnosis: nasal endoscopy + laryngoscopy, biopsy. Neck ultrasound/CT/MRI for extension. PET-CT for distant metastasis (lung, liver).

Treatment by stage: Stage I — radiotherapy or endoscopic laser surgery (organ-preserving). Stage II — radiotherapy ± small surgery. Stage III — concurrent chemoradiotherapy or surgery + radiotherapy. Stage IV — total laryngectomy (complete removal of the larynx; voice loss, tracheostomy) + radio + chemo.

Survival: Stage I 85-95%, Stage IV 20-30% — a 4-fold gap showing how critical early diagnosis is. Hoarseness >2 weeks, especially with smoking, must always be evaluated. For the related clinical reference, see larynx cancer page.

After cessation, what recovers in the vocal system and on what timeline? 1) First 48 hours: carbon monoxide normalises, oxygen reaches mucosa better. 2) First week: acute inflammation begins to regress, dryness eases. 3) 1-3 months: chronic inflammation regressing, voice tone improves slightly. 4) 6-12 months: Reinke's oedema partially regresses, voice approaches pre-smoking quality. 5) 5 years: laryngeal cancer risk halved. 6) 10 years: risk approaches that of a never-smoker (not equal but very close).

This timeline shows the benefit of stopping over time. Some structural changes (polyps, leukoplakia, structural damage) do not fully reverse — but progression halts and cancer risk drops dramatically.

Practical advice: 1) Cessation with professional support — 30-40% success; without — 5-10%. Nicotine replacement (patch, gum), varenicline (Champix), bupropion. 2) Yearly or 2-yearly laryngology exam — especially with long smoking history. 3) Reduce alcohol — combined with cessation is very powerful.

Passive smoke exposure (at home, work, smoking environments) causes measurable damage to the larynx — not as much as active smoking but real. Non-smokers chronically exposed show vocal cord changes; laryngeal cancer risk rises 20-30% over non-exposed.

This matters especially for children of indoor-smoking parents — childhood vocal cord development can be affected, with later allergy and airway sensitivity. Restricting smoking to outdoors helps but is not full protection; the smoker's breath and clothing carry exposure.

E-cigarettes (vapes): "safer" marketing is misleading. Less carcinogen-laden than tobacco but not risk-free. Diacetyl (the popcorn-butter aerosol chemical) causes "popcorn lung", a serious airway disease. For the vocal cords: e-cigarette nicotine + chemical aerosol = mucosal irritation + acute inflammation + long-term risk still unclear (not enough long studies).

Bottom line: e-cigarettes are not a "cessation tool". For cessation, professional support + pharmacotherapy (patch, varenicline) is safer. Switching to vapes is "less-bad than bad"; the real target is "neither". We share patient experiences on our second opinion service.